Mark J. Chicarelli

838 total citations
6 papers, 78 citations indexed

About

Mark J. Chicarelli is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Mark J. Chicarelli has authored 6 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Mark J. Chicarelli's work include Mast cells and histamine (2 papers), Pancreatic function and diabetes (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Mark J. Chicarelli is often cited by papers focused on Mast cells and histamine (2 papers), Pancreatic function and diabetes (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Mark J. Chicarelli collaborates with scholars based in United States. Mark J. Chicarelli's co-authors include Walter E. DeWolf, Stefan Groß, Eli Wallace, Patrice A. Lee, Steven A. Boyd, Kevin R. Condroski, Ira von Carlowitz, W.C. Voegtli, Peter Mohr and Bin Wang and has published in prestigious journals such as Blood, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Mark J. Chicarelli

6 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Chicarelli United States	5	61	28	24	12	10	6	78
Anke Vandekeere Belgium	6	95 1.6×	22 0.8×	8 0.3×	14 1.2×	8 0.8×	10	153
Jessica L. Minder United States	3	135 2.2×	18 0.6×	6 0.3×	30 2.5×	7 0.7×	4	161
Isabel Schulien Germany	3	56 0.9×	9 0.3×	12 0.5×	10 0.8×	11 1.1×	3	130
Kristina Juneblad Sweden	6	56 0.9×	30 1.1×	8 0.3×	5 0.4×	46 4.6×	9	122
Gregory Byram United States	4	76 1.2×	22 0.8×	22 0.9×	7 0.6×	5 0.5×	4	135
Tatiana Vasil'evna Nikonova Russia	5	30 0.5×	15 0.5×	23 1.0×	15 1.3×	6 0.6×	30	94
Matthew D. Falk United States	6	106 1.7×	9 0.3×	5 0.2×	18 1.5×	47 4.7×	6	132
Lisa Buci Italy	4	37 0.6×	26 0.9×	52 2.2×	8 0.7×	5 0.5×	5	84
Ilona Dahmen Germany	3	42 0.7×	17 0.6×	14 0.6×	21 1.8×	4 0.4×	3	86
José Ignacio Arias Pérez Spain	6	63 1.0×	44 1.6×	24 1.0×	31 2.6×	9 0.9×	10	142

Countries citing papers authored by Mark J. Chicarelli

Since Specialization

Citations

This map shows the geographic impact of Mark J. Chicarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Chicarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Chicarelli more than expected).

Fields of papers citing papers by Mark J. Chicarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Chicarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Chicarelli. The network helps show where Mark J. Chicarelli may publish in the future.

Co-authorship network of co-authors of Mark J. Chicarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Chicarelli. A scholar is included among the top collaborators of Mark J. Chicarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Chicarelli. Mark J. Chicarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Guarnieri, Anna L., Mark J. Chicarelli, Karyn Bouhana, et al.. (2021). Preclinical Data with KIT D816V Inhibitor Bezuclastinib (CGT9486) Demonstrates High Selectivity and Minimal Brain Penetrance. Blood. 138(Supplement 1). 4595–4595. 8 indexed citations

2.

Guarnieri, Anna L., Mark J. Chicarelli, Francis Sullivan, et al.. (2021). Abstract P257: Preclinical data identifies bezuclastinib as a differentiated KIT inhibitor with unique selectivity to KIT D816V and minimal evidence of brain penetration. Molecular Cancer Therapeutics. 20(12_Supplement). P257–P257. 1 indexed citations

3.

Marx, Matthew A., Brian R. Baer, Joshua A. Ballard, et al.. (2020). Abstract B30: Structure-based drug discovery of MRTX1257, a selective, covalent KRAS G12C inhibitor with oral activity in animal models of cancer. Molecular Cancer Research. 18(5_Supplement). B30–B30. 5 indexed citations

4.

Lü, Min, Pingping Li, Gautam Bandyopadhyay, et al.. (2014). Characterization of a Novel Glucokinase Activator in Rat and Mouse Models. PLoS ONE. 9(2). e88431–e88431. 16 indexed citations

5.

Hinklin, Ronald J., Steven A. Boyd, Mark J. Chicarelli, et al.. (2013). Identification of a New Class of Glucokinase Activators through Structure-Based Design. Journal of Medicinal Chemistry. 56(19). 7669–7678. 26 indexed citations

6.

Davies, Kurtis D., Michael Humphries, Francis X. Sullivan, et al.. (2011). Single-Agent Inhibition of Chk1 Is Antiproliferative in Human Cancer Cell Lines In Vitro and Inhibits Tumor Xenograft Growth In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(7). 349–363. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact